OTCBB: AXGN
Biotech company commercializing products for peripheral nerve injury repair and regeneration. 
Reverse merger with LecTec Corporation: OTCBB LECT.

Private
Pharmaceutical company specializing in painless transdermal delivery of insulin.
Investor Syndicate: Aperture Venture Partners, Domain Associates, KBC Private Equity, Quilvest Ventures, Rockport Venture Fund, Venrock, vSpring Capital


Private
Medical device company developing interventional bronchoscopy devices for the treatment of emphysema.
Investor Syndicate:
Abingworth Management, Boston Scientific, EDB Singapore,  HBM,  Pequot Ventures, Piper Jaffray,  Menlo Ventures,  Mitsui & Co.,   Oakwood Medical Management,  Pac-Link Management, 
Rockport Venture Fund, Venrock, vSpring Capital

Calypso

Acquired by Varian Medical Systems
Commercial stage medical device company with platform technology to actively track tumor position during radiation therapy.
Investor Syndicate:
Apothecary Capital, Bay City Capital, BB Biotech Ventures, Frazier Healthcare Ventures, Glenview, Kaiser Permanente, Mitsui & Co., Pequot Ventures, RiverVest Venture Partners, Rockport Venture Fund, Utah Ventures, Versant Ventures.

cardiomems

Private
Commercial stage medical device company with platform technology to accurately measure and wirelessly transmit vital cardiac information from inside the body.
Investor Syndicate:
Arboretum Ventures, Aperture, Arcapita Ventures, Boston Millennia, Deerfield Management, Easton Capital, Foundation Medical, Guidant, J&J, Medtronic, Rockport Venture Fund, Vision Capital.

Coaxia

Private
Developer of perfusion augmentation therapies for patients with cerebral ischemia resulting from stroke, vasospasm, and other conditions.
Investor Syndicate:
Affinity Capital Management, Baird Venture Partners, Canaan Partners, Johnson & Johnson, Prism Venture Partners, Saints, Sofinnova Partners

Combinatorx

NASDAQ: CRXX
Pharmaceutical company that discovers and develops novel synergistic combination medicines.
Investor Syndicate:
Adams Street, BioVentures,  Canaan Partners, CDIB,  Flagship Ventures,  Foundation Medical, Global Life Science Ventures,  Novartis, POSCO BioVentures,  TL Ventures.

endogastric

Private
Commercial stage company marketing devices to enable novel transoral incisionless procedures to treat gastrointestinal diseases
Investor Syndicate:
Advanced Technology Ventures, Canaan Partners, Chicago Growth, DeNovo, Foundation Medical,
MPM Capital, Oakwood Medical, Radius Ventures.

flowcardia

Acquired by C.R. Bard
Commercial stage company marketing devices to facilitate the crossing of totally occluded coronary and peripheral arteries
Investor Syndicate:
AM Pappas, Frazier Healthcare Ventures, Gilde Healthcare, H&Q Capital, Life Sciences Partners,
New Sciences Ventures,  Panorama Capital, Rockport Venture Fund.

iVenix

Private
Medical device company with breakthrough infusion pump platform technology for the hospital and home care markets. 
Investor Syndicate:
Cardinal Healthcare, CICA, Rockport Venture Fund, Univest

AMEX: IGI
IGI has developed topical delivery solutions based on its proprietary Novasome® lipid vesicle encapsulation technology
PIPE Investor Syndicate:
Signet Healthcare Partners

Screen Shot 2015-05-31 at 12.11.16 AM

Private
One step, office-based, non-invasive diagnostic for Alzheimer's disease
Investor Syndicate:
Inventages

NASDAQ: NSTR
Northstar Neuroscience is pioneering the development of cortical stimulation therapies
Investor Syndicate:
AEA Investors, Boston Scientific, Canaan Partners, Domain Associates, Foundation Medical Partners, HBM Partners, J&J Development Corp, Mayfield Fund, SEB Asset Management.

Acquired by Septodont
Commercial stage pharmaceutical company developing innovative therapies for the dental healthcare market
Investor Syndicate:
Boston Millennia Partners, Domain Associates, Genevest Consulting Group, Montreux Equity Partners, New Enterprise Associates, S.R. One

Private
Specialty pharmaceutical and medical device company offering a new approach to the management of postoperative pain.
Investor Syndicate:
BB Biotech Ventures, Canaan Partners, ProQuest Investments, Rockport Venture Fund

Private
Medical device company with a portfolio of programmable implantable drug delivery devices
Investor Syndicate:
Arcus Ventures, Baird Ventures, BB Biotech Ventures, Cross Atlantic Partners, Fountain Healthcare Partners, Hambrecht & Quist, Nextech Ventures.

Private
Medical device company developing a treatment for obstructive sleep apnea with a minimal invasive implant system.

Acquired by Salix for $2.6 Billion
Pharmaceutical company focused on the prevention & treatment of gastrointestinal diseases and disorders
Investor Syndicate:
Advent Venture Partners, CDIB, Domain Associates, Hamilton Apex, Life Science Partners, Panorama Capital, Split Rock, S.R. One, Windamere Venture Partners

Acquired by Pfizer
Pharmaceutical company developing best-in-class therapeutic and supportive care products for multiple clinical indications
Investor Syndicate:
InterSouth Partners, Lilly Ventures, Mediphase Venture Partners, Mitsubishi, Pac-Link Management, Ritchie Capital, Rockport Venture Fund, Takeda

Private
Commercial stage company with an implantable device to improve vision in individuals with end-stage age-related macular degeneration
Investor Syndicate:
Boston Scientific, BSI, Giza Ventures, Infinity, ONSET Ventures, Pitango, Saints Capital, Three Arch Partners

Acquired by Alcon
Commercial stage medical device company with a system for intra-operative decision making support to improve vision correction procedures
Investor Syndicate:
Burrill & Company, Versant Ventures, Accuitive Medical Ventures, De Novo Ventures and Gund Investment Corporation